Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Editorial Volume 6 Issue 2

Combating Covid-19 Vaccine Hesitancy

Suprakash Chaudhury*, Tahoora Ali and Daniel Saldanha

Department of Psychiatry, Dr D Y Patil Medical College, Hospital and Research Centre, Dr D Y Patil University, Pimpri, Pune, India

*Corresponding Author: Suprakash Chaudhury, Department of Psychiatry, Dr D Y Patil Medical College, Hospital and Research Centre, Dr D Y Patil University, Pimpri, Pune, India.

Received: November 24, 2022; Published: January 01, 2023

Abstract

Vaccination can be regarded as one of the safest modes of medical management, owing to the fact that it’s constructed for administration to perfectly healthy individuals [1]. Due to the historical evidence to strengthen its claim, and the eradication of certain diseases following universal vaccination, vaccines have been accepted all over the globe. However, there do remain individuals or groups and sects, who harbour aversion to vaccines; who either completely refuse the administration of vaccines or who practice considerably delayed administration, owing to their scepticism. Studies have often reflected bleak confidence of the general population in the procedure and outcome of vaccination, even in those compliant with the prevalent norms of vaccination.

References

  1. Schwartz JL. “New media, old messages: themes in the history of vaccine hesitancy and refusal”. AMA Journal of Ethics1 (2012): 50-55.
  2. MacDonald NE. “Vaccine hesitancy: Definition, scope and determinants”. Vaccine 34 (2015): 4161-4164.
  3. Dubé E. “Addressing vaccine hesitancy: the crucial role of healthcare providers”. Clinical Microbiology and Infection 5 (2017): 279-280.
  4. Jacobson RM., et al. “Vaccine hesitancy”. In Mayo Clinic Proceedings 90.11 (2015): 1562-1568. Elsevier.
  5. Ali T., et al. “Dangers of mRNA vaccines”. Industrial Psychiatry Journal 3 (2021): 291.
  6. Chaudhury S., et al. “COVID 19 Vaccine Hesitancy”. Acta Scientific Neurology 3 (2021): 01-02.
  7. Soares P., et al. “Factors associated with COVID-19 vaccine hesitancy”. Vaccines 3 (2021): 300.
  8. Mohammed AM., et al. “Socio-demographics correlate of COVID-19 vaccine hesitancy during the second wave of COVID-19 pandemic: a cross-sectional web-based survey in Saudi Arabia”. Frontiers in Public Health (2021): 9.
  9. Machingaidze S and Wiysonge CS. “Understanding COVID-19 vaccine hesitancy”. Nature Medicine 8 (2021): 1338-1339.
  10. McAteer J., et al. “The VACCINES Act: deciphering vaccine hesitancy in the time of COVID-19”. Clinical Infectious Diseases15 (2020): 703-705.

Citation

Citation: Suprakash Chaudhury., et al. “Combating Covid-19 Vaccine Hesitancy". Acta Scientific Neurology 6.2 (2023): 01-02.

Copyright

Copyright: © 2023 Suprakash Chaudhury., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US